Literature DB >> 26715601

Nuclear imaging for patients with a suspicion of infective endocarditis: Be part of the team!

Fabien Hyafil1, François Rouzet2, Dominique Le Guludec2.   

Abstract

The diagnosis of infective endocarditis (IE) is challenging and requires the association of morphological features suggestive of valvular infection such as the presence of vegetations or abscesses identified usually with echocardiography and positive blood culture or serologies suggestive of systemic bacterial infection. In the past 5 years, several groups confirmed the incremental value of FDG-PET imaging and radiolabeled leukocyte scintigraphy over echocardiography for the diagnosis of IE. Based on the latter studies, the presence of abnormal activity in the perivalvular region on either FDG-PET imaging or radiolabeled leukocyte scintigraphy has been added as a major criterion for the diagnosis of IE in the guidelines recently published. Nuclear physicians should therefore learn not only the imaging criteria in favor of active IE but also the pitfalls of these nuclear imaging techniques in order to give a useful answer to the referring physician for the management of these patients. In fact, the diagnosis of IE is often complex and requires the integration of multiple clinical, biological, and imaging parameters. Multi-disciplinary teams including cardiologists, infectious disease physicians, cardiac surgeons, and radiologists have been therefore set up in several institutions to discuss the diagnosis and management of patients with a suspicion of IE. It is now time for nuclear cardiologists to join the team.

Entities:  

Keywords:  Fluorodeoxyglucose (FDG); PET/CT imaging; endocarditis; leukocyte scintigraphy; radiolabeled; valvular heart disease

Mesh:

Substances:

Year:  2015        PMID: 26715601     DOI: 10.1007/s12350-015-0369-z

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  15 in total

1.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis.

Authors:  J S Li; D J Sexton; N Mick; R Nettles; V G Fowler; T Ryan; T Bashore; G R Corey
Journal:  Clin Infect Dis       Date:  2000-04-03       Impact factor: 9.079

Review 2.  Variability and uncertainty of 18F-FDG PET imaging protocols for assessing inflammation in atherosclerosis: suggestions for improvement.

Authors:  Pauline Huet; Samuel Burg; Dominique Le Guludec; Fabien Hyafil; Irène Buvat
Journal:  J Nucl Med       Date:  2015-02-26       Impact factor: 10.057

3.  Improving the Diagnosis of Infective Endocarditis in Prosthetic Valves and Intracardiac Devices With 18F-Fluordeoxyglucose Positron Emission Tomography/Computed Tomography Angiography: Initial Results at an Infective Endocarditis Referral Center.

Authors:  María N Pizzi; Albert Roque; Nuria Fernández-Hidalgo; Hug Cuéllar-Calabria; Ignacio Ferreira-González; María T Gonzàlez-Alujas; Gerard Oristrell; Laura Gracia-Sánchez; Juan J González; José Rodríguez-Palomares; Manuel Galiñanes; Olga Maisterra-Santos; David Garcia-Dorado; Joan Castell-Conesa; Benito Almirante; Santiago Aguadé-Bruix; Pilar Tornos
Journal:  Circulation       Date:  2015-08-14       Impact factor: 29.690

4.  Detection of Mycotic Aneurysms of Lower Limbs by Whole-Body (18)F-FDG-PET.

Authors:  Nidaa Mikail; Khadija Benali; Phalla Ou; Jerome Slama; Fabien Hyafil; Dominique Le Guludec; Francois Rouzet
Journal:  JACC Cardiovasc Imaging       Date:  2015-07

Review 5.  Clinical practice. Infective endocarditis.

Authors:  Bruno Hoen; Xavier Duval
Journal:  N Engl J Med       Date:  2013-04-11       Impact factor: 91.245

6.  Added value of 99mTc-HMPAO-labeled leukocyte SPECT/CT in the characterization and management of patients with infectious endocarditis.

Authors:  Paola A Erba; Umberto Conti; Elena Lazzeri; Martina Sollini; Roberta Doria; Salvatore M De Tommasi; Francesco Bandera; Carlo Tascini; Francesco Menichetti; Rudi A J O Dierckx; Alberto Signore; Giuliano Mariani
Journal:  J Nucl Med       Date:  2012-07-11       Impact factor: 10.057

7.  Role of radiolabelled leucocyte scintigraphy in patients with a suspicion of prosthetic valve endocarditis and inconclusive echocardiography.

Authors:  Fabien Hyafil; François Rouzet; Laurent Lepage; Khadija Benali; Richard Raffoul; Xavier Duval; Ulrik Hvass; Bernard Iung; Patrick Nataf; Rachida Lebtahi; Alec Vahanian; Dominique Le Guludec
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2013-03-01       Impact factor: 6.875

8.  High 18F-FDG Uptake in synthetic aortic vascular grafts on PET/CT in symptomatic and asymptomatic patients.

Authors:  Johan Wassélius; Jonas Malmstedt; Bo Kalin; Stig Larsson; Anders Sundin; Ulf Hedin; Hans Jacobsson
Journal:  J Nucl Med       Date:  2008-09-15       Impact factor: 10.057

9.  18F-FDG positron emission tomography/computed tomography in infective endocarditis.

Authors:  Soile Pauliina Salomäki; Antti Saraste; Jukka Kemppainen; Jeroen J Bax; Juhani Knuuti; Pirjo Nuutila; Marko Seppänen; Anne Roivainen; Juhani Airaksinen; Laura Pirilä; Jarmo Oksi; Ulla Hohenthal
Journal:  J Nucl Cardiol       Date:  2015-12-09       Impact factor: 5.952

Review 10.  The use of (18)F-FDG-PET/CT for diagnosis and treatment monitoring of inflammatory and infectious diseases.

Authors:  Andor W J M Glaudemans; Erik F J de Vries; Filippo Galli; Rudi A J O Dierckx; Riemer H J A Slart; Alberto Signore
Journal:  Clin Dev Immunol       Date:  2013-08-21
View more
  9 in total

1.  Quantification of FDG uptake in patients with a suspicion of prosthetic valve endocarditis: Part of the problem or part of the solution?

Authors:  Fabien Hyafil; François Rouzet; Dominique Le Guludec
Journal:  J Nucl Cardiol       Date:  2017-07-24       Impact factor: 5.952

2.  FDG PET/CT in prosthetic heart valve endocarditis: There is no need to wait.

Authors:  A M Scholtens; R P J Budde; M G E H Lam; H J Verberne
Journal:  J Nucl Cardiol       Date:  2017-05-30       Impact factor: 5.952

3.  Optimizing patient centered care in the cardiac intensive care unit: Harness the safety, effectiveness, and incremental value of radionuclide perfusion, function, and molecular imaging.

Authors:  Peter A Bleszynski; Ronald G Schwartz
Journal:  J Nucl Cardiol       Date:  2021-06-24       Impact factor: 5.952

Review 4.  Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2017. Part 1 of 2: Positron emission tomography, computed tomography, and magnetic resonance.

Authors:  Wael A AlJaroudi; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2017-11-08       Impact factor: 5.952

5.  FDG-PET for the detection of infection in left ventricle assist device: Is there light at the end of the tunnel?

Authors:  Fabien Hyafil; François Rouzet; Khadija Benali
Journal:  J Nucl Cardiol       Date:  2018-02-01       Impact factor: 5.952

Review 6.  Utility of nuclear cardiovascular imaging in the cardiac intensive care unit.

Authors:  Aldo L Schenone; Erika Hutt; Paul Cremer; Wael A Jaber
Journal:  J Nucl Cardiol       Date:  2021-06-09       Impact factor: 5.952

7.  Turning the heart off: give it a second try?

Authors:  Nidaa Mikail; Fabien Hyafil
Journal:  J Nucl Cardiol       Date:  2022-06-02       Impact factor: 5.952

8.  Procedural recommendations of cardiac PET/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation- (4Is) related cardiovascular diseases: a joint collaboration of the EACVI and the EANM: summary.

Authors:  Riemer H J A Slart; Andor W J M Glaudemans; Olivier Gheysens; Mark Lubberink; Tanja Kero; Marc R Dweck; Gilbert Habib; Oliver Gaemperli; Antti Saraste; Alessia Gimelli; Panagiotis Georgoulias; Hein J Verberne; Jan Bucerius; Christoph Rischpler; Fabien Hyafil; Paola A Erba
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2020-12-01       Impact factor: 6.875

9.  Procedural recommendations of cardiac PET/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation (4Is)-related cardiovascular diseases: a joint collaboration of the EACVI and the EANM.

Authors:  Riemer H J A Slart; Andor W J M Glaudemans; Olivier Gheysens; Mark Lubberink; Tanja Kero; Marc R Dweck; Gilbert Habib; Oliver Gaemperli; Antti Saraste; Alessia Gimelli; Panagiotis Georgoulias; Hein J Verberne; Jan Bucerius; Christoph Rischpler; Fabien Hyafil; Paola A Erba
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-10-27       Impact factor: 9.236

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.